Identification of genetic modifiers of monogenic (bone) diseases: New tools available, but with limitations

Journal of Bone and Mineral Research

Volumn 26, Issue 5, 2011, Pages 918-919

  Van Hul, Wim ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TRANSFORMING GROWTH FACTOR BETA1;

CAMURATI ENGELMANN DISEASE; DNA POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOSITY; HUMAN; MISSENSE MUTATION; NOTE;

BONE AND BONES; BONE DISEASES; FAMILY; FEMALE; HUMANS; MALE; MUTATION; RANK LIGAND; TRANSFORMING GROWTH FACTOR BETA1;

EID: 79955628932     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.391     Document Type: Note

References (10)

1. Whyte MP, Totty WG, Novack DV, Zhang X, Wenkert D, Mumm S., Camurati-Engelmann Disease: unique variant featuring a novel mutation in TGFβ1 encoding transforming growth factor beta 1 and a missense change in TNFSF11 encoding RANK ligand. J Bone Miner Res. 2011; 26: 920-933.
2. Janssens K, Gershoni-Baruch R, Guanabens N, et al. Mutations in the gene encoding the latency-associated peptide of TGF-beta 1 cause Camurati-Engelmann disease. Nat Genet. 2000; 26: 273-275.
3. Kinoshita A, Saito T, Tomita H, et al. Domain-specific mutations in TGFB1 result in Camurati-Engelmann disease. Nat Genet. 2000; 26: 19-20.
4. Janssens K, Vanhoenacker F, Bonduelle M, et al. Camurati-Engelmann disease: review of the clinical, radiological, and molecular data of 24 families and implications for diagnosis and treatment. J Med Genet. 2006; 43: 1-11. (Pubitemid 43099989)
5. Hughes AE, Ralston SH, Marken J, et al. Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis. Nat Genet. 2000; 24: 45-48. (Pubitemid 30041418)
6. Crockett JC, Mellis DJ, Scott DI, Helfrich MH., New knowledge on critical osteoclast formation and activation pathways from study of rare genetic diseases of osteoclasts: focus on the RANK/RANKL axis. Osteoporos Int. 2011; 22: 1-20.
7. Janssens K, ten Dijke P, Ralston SH, Bergmann C, Van Hul W., Transforming growth factor-beta 1 mutations in Camurati-Engelmann disease lead to increased signaling by altering either activation or secretion of the mutant protein. J Biol Chem. 2003; 278: 7718-7724. (Pubitemid 36800782)
8. Tang Y, Wu X, Lei W, et al. TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med. 2009; 15: 757-765.
9. Quinn JM, Itoh K, Udagawa N, et al. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions. J Bone Miner Res. 2001; 16: 1787-1794. (Pubitemid 32911484)
10. Sudmant PH, Kitzman JO, Antonacci F, et al. Diversity of human copy number variation and multicopy genes. Science. 2010; 330: 641-646.